Patents by Inventor Mark J. Rice
Mark J. Rice has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20240074529Abstract: A sensor system is adapted for use with an article of footwear and includes an insert member including a first layer and a second layer, a port connected to the insert and configured for communication with an electronic module, a plurality of force and/or pressure sensors on the insert member, and a plurality of leads connecting the sensors to the port.Type: ApplicationFiled: September 19, 2023Publication date: March 7, 2024Inventors: Michael S. Amos, Andrew A. Owings, Jordan M. Rice, Allan M. Schrock, Steven H. Walker, Jeffrey J. Hebert, Martine W. Stillman, Mark A. Tempel, Dane Weitmann, Andreas Heinrich Steier, Ndikum Protus Atang
-
Patent number: 11206278Abstract: Technology related to risk-informed autonomous adaptive cyber controllers is disclosed. In one example of the disclosed technology, a method includes generating probabilities of a cyber-attack occurring along an attack surface of a network. The probabilities can be generated using sensor and operational data of a network as inputs to an attack graph. The risk scores can be determined using a plurality of fault trees and the generated probabilities from the attack graph. The respective risk scores can correspond to respective nodes of an event tree. The event tree and the determined risk scores can be used to determine risk estimates for a plurality of configurations of the network. The risk estimates for the plurality of configurations of the network can be used to reconfigure the network to reduce a risk from the cyber-attack.Type: GrantFiled: June 5, 2019Date of Patent: December 21, 2021Assignee: Battelle Memorial InstituteInventors: Arun Veeramany, William James Hutton, III, Siddharth Sridhar, Sri Nikhil Gupta Gourisetti, Garill A. Coles, Mark J. Rice, Paul M. Skare, David O. Manz, Jeffery E. Dagle, Stephen D. Unwin
-
Publication number: 20200244691Abstract: Technology related to risk-informed autonomous adaptive cyber controllers is disclosed. In one example of the disclosed technology, a method includes generating probabilities of a cyber-attack occurring along an attack surface of a network. The probabilities can be generated using sensor and operational data of a network as inputs to an attack graph. The risk scores can be determined using a plurality of fault trees and the generated probabilities from the attack graph. The respective risk scores can correspond to respective nodes of an event tree. The event tree and the determined risk scores can be used to determine risk estimates for a plurality of configurations of the network. The risk estimates for the plurality of configurations of the network can be used to reconfigure the network to reduce a risk from the cyber-attack.Type: ApplicationFiled: June 5, 2019Publication date: July 30, 2020Applicant: Battelle Memorial InstituteInventors: Arun Veeramany, William James Hutton, III, Siddharth Sridhar, Sri Nikhil Gupta Gourisetti, Garill A. Coles, Mark J. Rice, Paul M. Skare, David O. Manz, Jeffery E. Dagle, Stephen D. Unwin
-
Patent number: 9995757Abstract: The disclosure provides methods, kits, and devices for determining an amount of hemoglobin S and/or an amount of total hemoglobin, and optionally, expressing the amount of hemoglobin S as a percentage. Devices of the disclosure may be used as point-of-care diagnostic systems accessible for use to a layperson, i.e., an individual with minimal or no medical training or expertise.Type: GrantFiled: September 9, 2014Date of Patent: June 12, 2018Assignee: University of Florida Research Foundation, Inc.Inventors: Mark J. Rice, Lindsay Bazydlo, Timothy E. Morey
-
Publication number: 20160216280Abstract: The disclosure provides methods, kits, and devices for determining an amount of hemoglobin S and/or an amount of total hemoglobin, and optionally, expressing the amount of hemoglobin S as a percentage. Devices of the disclosure may be used as point-of-care diagnostic systems accessible for use to a layperson, i.e., an individual with minimal or no medical training or expertise.Type: ApplicationFiled: September 9, 2014Publication date: July 28, 2016Applicant: University of Florida Research Foundation, Inc.Inventors: Mark J. RICE, Lindsay BAZYDLO, Timothy E. MOREY
-
Publication number: 20150094965Abstract: Electrical power grid monitoring apparatus, articles of manufacture, and methods of monitoring equipment of an electrical power grid are described.Type: ApplicationFiled: September 30, 2013Publication date: April 2, 2015Applicant: Battelle Memorial InstituteInventors: Kevin P. Schneider, Mark J. Rice, Tess L. Williams, Beau B. Van Kirk, III
-
Patent number: 6895264Abstract: Blood glucose concentrations are measured by non-invasive methods and apparatus using visual pigment bleaching in conjunction with psychophysical methodologies. Bleaching light of selected wavelengths is projected through the pupil of the eye of an observer onto the fundus to bleach visual pigments in the eye. The observer's psychophysical response to a visual stimulus is then measured to obtain information regarding the rate of regeneration of the visual pigments. From the rate of pigment regeneration, blood glucose concentrations are measured accurately. The psychophysical methodologies that may be used with the invention include visual acuity tests and color-matching tests.Type: GrantFiled: August 15, 2003Date of Patent: May 17, 2005Assignee: Fovioptics Inc.Inventors: Mark J. Rice, Joe W. Woods, Wilson Routt, Junli Ou
-
Patent number: 6889069Abstract: The determination of blood glucose in an individual is carried out by projecting illuminating light into an eye of the individual to illuminate the retina with the light having wavelengths that are absorbed by rhodopsin and with the intensity of the light varying in a prescribed temporal manner. The light reflected from the retina is detected to provide a signal corresponding to the intensity of the detected light, and the detected light signal is analyzed to determine the changes in form from that of the illuminating light. For a biased sinusoidal illumination, these changes can be expressed in terms of harmonic content of the detected light. The changes in form of the detected light are related to the ability of rhodopsin to absorb light and regenerate, which in turn is related to the concentration of blood glucose, allowing a determination of the relative concentration of blood glucose.Type: GrantFiled: August 15, 2003Date of Patent: May 3, 2005Assignee: Fovioptics Inc.Inventors: Wilson Routt, Mark J. Rice
-
Publication number: 20040147820Abstract: The determination of blood glucose in an individual is carried out by projecting illuminating light into an eye of the individual to illuminate the retina with the light having wavelengths that are absorbed by rhodopsin and with the intensity of the light varying in a prescribed temporal manner. The light reflected from the retina is detected to provide a signal corresponding to the intensity of the detected light, and the detected light signal is analyzed to determine the changes in form from that of the illuminating light. For a biased sinusoidal illumination, these changes can be expressed in terms of harmonic content of the detected light. The changes in form of the detected light are related to the ability of rhodopsin to absorb light and regenerate, which in turn is related to the concentration of blood glucose, allowing a determination of the relative concentration of blood glucose.Type: ApplicationFiled: August 15, 2003Publication date: July 29, 2004Applicant: Fovioptics, Inc.Inventors: Wilson Routt, Mark J. Rice
-
Publication number: 20040087843Abstract: Blood glucose concentrations are measured by non-invasive methods and apparatus using visual pigment bleaching in conjunction with psychophysical methodologies. Bleaching light of selected wavelengths is projected through the pupil of the eye of an observer onto the fundus to bleach visual pigments in the eye. The observer's psychophysical response to a visual stimulus is then measured to obtain information regarding the rate of regeneration of the visual pigments. From the rate of pigment regeneration, blood glucose concentrations are measured accurately. The psychophysical methodologies that may be used with the invention include visual acuity tests and color-matching tests.Type: ApplicationFiled: August 15, 2003Publication date: May 6, 2004Inventors: Mark J. Rice, Joe W. Woods, Wilson Routt, Junli Ou
-
Patent number: 6650915Abstract: The determination of blood glucose in an individual is carried out by projecting illuminating light into an eye of the individual to illuminate the retina with the light having wavelengths that are absorbed by rhodopsin and with the intensity of the light varying in a prescribed temporal manner. The light reflected from the retina is detected to provide a signal corresponding to the intensity of the detected light, and the detected light signal is analyzed to determine the changes in form from that of the illuminating light. For a biased sinusoidal illumination, these changes can be expressed in terms of harmonic content of the detected light. The changes in form of the detected light are related to the ability of rhodopsin to absorb light and regenerate, which in turn is related to the concentration of blood glucose, allowing a determination of the relative concentration of blood glucose.Type: GrantFiled: October 22, 2001Date of Patent: November 18, 2003Assignee: Fovioptics, Inc.Inventors: Wilson Routt, Mark J. Rice
-
Patent number: 6537207Abstract: A protective cover for medical imaging devices of the type having a probe with an optical system at a distal end includes a sheath of plastic material formed to enclose at least a portion of the probe and a transparent head secured to the sheath at a distal end of the cover. The transparent head provides a transparent window at the distal end of the probe to allow light to enter the probe and be imaged in a normal manner. Indicia are formed on the transparent head and are imaged by the medical imaging device. The image is then analyzed to determine if the indicia as shown in the image correspond to a preselected pattern, which may be one of a group of patterns which provide indications concerning the nature of the cover. If a pattern is recognized, the information corresponding to that pattern can be provided to an operator; if no pattern is recognized or if the pattern corresponds to an improper cover for the particular imaging device, a warning can be provided to the operator or the device disabled.Type: GrantFiled: October 5, 2001Date of Patent: March 25, 2003Assignee: Fovioptics, Inc.Inventors: Mark J. Rice, Steve Spanoudis
-
Publication number: 20030050544Abstract: The determination of blood glucose in an individual is carried out by projecting illuminating light into an eye of the individual to illuminate the retina with the light having wavelengths that are absorbed by rhodopsin and with the intensity of the light varying in a prescribed temporal manner. The light reflected from the retina is detected to provide a signal corresponding to the intensity of the detected light, and the detected light signal is analyzed to determine the changes in form from that of the illuminating light. For a biased sinusoidal illumination, these changes can be expressed in terms of harmonic content of the detected light. The changes in form of the detected light are related to the ability of rhodopsin to absorb light and regenerate, which in turn is related to the concentration of blood glucose, allowing a determination of the relative concentration of blood glucose.Type: ApplicationFiled: October 22, 2001Publication date: March 13, 2003Inventors: Wilson Routt, Mark J. Rice
-
Patent number: 6477394Abstract: Illuminating light of selected wavelengths in the visible or infrared range is projected through the pupil of the eye onto the fundus, and the light reflected back and out through the pupil is detected and analyzed, preferably using the area of the optic disk for analyzing the retinal vessels overlying the optic disk. Specific wavelengths of illuminating light may be chosen for each blood component to be analyzed depending on the spectral characteristics of the substance being analyzed. The reflected image from the retina may be used to measure non-photoreactive blood components such as hemoglobin, and photoreactive components such as bilirubin. For the measurement of photoreactive components, images may be taken before and after, or during, illumination of the eye with light at wavelengths which will affect the photoreactive analyte, enabling measurements of the concentration of the analyte.Type: GrantFiled: September 12, 2001Date of Patent: November 5, 2002Assignee: Fovioptics, Inc.Inventors: Mark J. Rice, Robert H. Sweat, Jr., James M. Rioux, William T. Williams, Wilson Routt
-
Publication number: 20020072658Abstract: Illuminating light of selected wavelengths in the visible or infrared range is projected through the pupil of the eye onto the fundus, and the light reflected back and out through the pupil is detected and analyzed, preferably using the area of the optic disk for analyzing the retinal vessels overlying the optic disk. Specific wavelengths of illuminating light may be chosen for each blood component to be analyzed depending on the spectral characteristics of the substance being analyzed. The reflected image from the retina may be used to measure non-photoreactive blood components such as hemoglobin, and photoreactive components such as bilirubin. For the measurement of photoreactive components, images may be taken before and after, or during, illumination of the eye with light at wavelengths which will affect the photoreactive analyte, enabling measurements of the concentration of the analyte.Type: ApplicationFiled: September 12, 2001Publication date: June 13, 2002Applicant: Fovioptics, Inc.Inventors: Mark J. Rice, Robert H. Sweat, James M. Rioux, William T. Williams, Wilson Routt
-
Patent number: 6305804Abstract: Illuminating light of selected wavelengths in the visible or infrared range is projected through the pupil of the eye onto the fundus, and the light reflected back and out through the pupil is detected and analyzed, preferably using the area of the optic disk for analyzing the retinal vessels overlying the optic disk. Specific wavelengths of illuminating light may be chosen for each blood component to be analyzed depending on the spectral characteristics of the substance being analyzed. The reflected image from the retina may be used to measure non-photoreactive blood components such as hemoglobin, and photoreactive components such as bilirubin. For the measurement of photoreactive components, images may be taken before and after, or during, illumination of the eye with light at wavelengths which will affect the photoreactive analyte, enabling measurements of the concentration of the analyte.Type: GrantFiled: March 24, 2000Date of Patent: October 23, 2001Assignee: Fovioptics, Inc.Inventors: Mark J. Rice, Robert H. Sweat, Jr., James M. Rioux, William T. Williams, Wilson Routt
-
Patent number: 5743849Abstract: A disposable protective sleeve used for covering laryngoscopes has a sheath and a shield integrally formed of a flexible material. The sheath defines a hollow cavity adapted to enclose a laryngoscope blade. The shield is attached to the sheath and is suited to cover a portion of the laryngoscope handle. The disposable sleeve is molded of a flexible plastic in a size and shape to conform to a particular size and shape of laryngoscope blade. After use, the sleeve is disposed of and the laryngoscope is covered with a new sleeve before being used again.Type: GrantFiled: August 9, 1996Date of Patent: April 28, 1998Assignee: Blue Ridge Products, LPInventors: Mark J. Rice, William T. Kearney, III, William T. Williams, Ganesh V. Phatak, Timothy P. Maupin